One of the biggest problems facing nanoscience is moving from pottering around in a lab doing something fascinating to translational research, i.e. taking that process or material and moving it in the direction of something that may be of use to someone for reasons other than writing publications. In the early days of nanotech, with investors fired up be the ‘new industrial revolution’ and mixing up nanoscience with the more far flung ideas about nanobots and terrforming Mars, starting up companies to cash in on the coming boom was relatively easy.

In 2010, given the current economic climate, it is much harder to raise any funding, and almost impossible to winkle scientists out of a lab job into the risky world of start up companies. As a result, much of the potential of nanotech risks either going unexploited for a while, or getting transferred only into large well funded companies, which is a shame.

There are ways around this, and Taiwan’s ITRI has just launched a Global Nano Innovation Contest to try to

  • Develop nanotechnology prototyping capability for practical applications with universal appeal.
  • Emphasize higher, system-level integration of prototypes, to spur the creation of a wider diversity of high-value nanotechnology applications.
  • Establish an international platform promoting collaboration on nanotechnology.

The top prize is US$15,000, and full details are here.

One word of caution, I’m one of the judges!

Tagged with:
 

Since the UK’s new nanotechnology strategy was launched I have been either having a crash course in regenerative medicine or getting over a cold. In the meantime, my colleagues Andrew Maynard and Dexter Johnson have both taken a long hard look at the ‘strategy’ and found it wanting. No, I’m being kind, the general consensus is that it is total rubbish that makes the UK an international laughing stock. Why?

  1. The entire strategy seems to have written by the kind of people who spend the first hour of a meeting explaining what to do in the event of an emergency, such as a leaky pen, and then don fluorescent jackets and hard hats to indemnify themselves the consequences of one of their number being hit by a meteorite. It’s all about public consultation, risk assessment and regulation, in fact anything that involves anything other than having meetings is excluded from the ‘strategy’.
  2. The strategy seems to have been written by people too lazy to do any research. The evidence is damning as the report makes no reference to any of the previous UK nanotechnology strategy reports, and quotes entirely different numbers. Could it be that everyone on the comittee that produced this monstrosity was too dim to use Google, or simply too lazy?
  3. The numbers just don’t add up. The report claims that “The global market in nano-enabled products is expected to grow from $2.3 billion in 2007 to $81 billion by 2015″ – a far cry from the also derided $2-3 trillion market numbers. I know that one of the organisations involved in this report spent a large amount of money for us to dig out the real numbers, and then apparently chucked it in a bin and grabbed the first thing they could find on the Internet instead. No wonder the UK has such a huge national debt!

I suspect the emphasis on talking rather than doing is because someone in BIS knows the true scale of the UK national debt and has realised that there won’t be any money available to implement anything anyway.  Let’s face it, in the six years since the RS report the entire UK nanotechnology strategy has involved the setting up of meetings, agencies, committees and public consultation so that we can worry about possible dangers and improve regulation. Meanwhile important areas, or indeed anything that works have been slashed, the UKs involvement in nanotechnology standards for example or the Nano & Me website.

Can we be absolutely clear? Spending six years calling for more discussion and setting up ever more steering groups to engage ever more stakeholders is not a strategy. Figuring out a way to move the excellent basic science in the UK into the economy would be, but this seem beyond the remit of this report.

Calling four government departments a bunch of dimwits probably won’t get us much work in the UK,  but the truth is that we don’t do any UK government consulting work. I was told by a senior civil servant at what was the Department for Trade and Industry back in 2002 that if they gave any work to Cientifica then the Institute of Nanotechnology would ‘go spare’ and as a result they were unable to work with or support either organisation. In the meantime we’ve developed strategies and dug out numbers for governments around the world, and despite being London based we have been roundly ignored by the UK Government who seem far more eager to promote anyone other than UK companies. Every UK nanotech report to date has excluded any data provided by UK companies. Even offers of free copies of our market research to government committees looking into various bits of nanotechnology provoke the same response as if we’d offered them a fresh dog turd wrapped in newspaper.

The real tragedy is that by publishing ridiculous documents like this it devalues the work of the entire science and business community. I know that there are some great people looking at nanotechnologies in BIS, in the TSB and of course Lord Drayson is no fool when it comes to science, but this seems to be a case where the whole is far, far less than the sum of its constituent parts.

My esteemed (and allegedly cute) colleague Dexter Johnson comments on a number of recent nanoparticle toxicity projects and wonders what is the point of them. I’ve often asked the same question (and been asked to leave the room as a result), but there does seem to be a weird academic bias towards reviews and public consultation and I think I know why.

On several occasions when I’ve been in a bar with eminent toxicologists they have admitted that there is absolutely no way that we could ever understand the toxicology of every kind of nanoparticle, and there is no point in trying. What you can do is draw broad conclusions, so that if we have a high aspect ratio structure such as a long carbon nanotube we know that it won’t be cleared by an alveolar macrophage etc, and then we usually get into a discussion about whether anyone is ever likely to inhale enough of the stuff to have a problem, given that we treat most nanomaterials with rather more caution than we did asbestos.

So for most toxicologists the choice is clear. Get paid to do some science or sit about for a bit?

When toxicologists ask for a global well funded long term study to allow the modelling of the interaction of various categories of nanomaterials with the environment, the funding agencies can only manage rustle up a few hundred thousand euros for a two or three year project. That gets you nowhere in understanding a new and rapidly emerging class of materials, so we just end up paying great scientists to sit on their backsides and browse the web for a few years.

Tagged with:
 

Stop that talk of nanobots, this is getting silly!

The UK Ministry of Defence released its latest ‘Global Strategic Trends – Out to 2040‘ study last month, and it’s a good read (even for non spooks) covering everything from terrorism to to climate change and their impact on geopolitics.

The report identifies four key issues, Globalisation, Climate Change, Global Inequality & Innovation which will dominate the next thirty years. The first three are fairly obvious, but I liked the rather rational approach to innovation which seems to put the military at odds with much of the ‘Cleantech industry.’

Innovation and technology will continue to facilitate change. Energy efficient technologies will become available, although a breakthrough in alternative forms of energy that reduces dependency on hydrocarbons is unlikely. The most significant innovations are likely to involve sensors, electro-optics and materials. Application of nano-technologies, whether through materials or devices, will become pervasive and diverse, particularly in synthetic reproduction, novel power sources, and health care. Improvements in health care, for those who can afford it, are likely to significantly enhance longevity and quality of life.

For those interested in how the military see nanotechnologies, there is a specific mention:

Nanotechnology focuses on manipulating matter at the atomic and molecular scale, generally at less than 100 nanometres in size. At this size, and using other scientific disciplines, the characteristics of matter can be changed. This will create new and unique properties with profound and diverse applications. Advances in nanotechnology, at the interdisciplinary frontier where physics, chemistry and biology meet, will be a key enabler of technological advance, involving: new additives and coatings; materials and sensor development; and medical treatments and heath diagnosis. Products will be smaller and more energy efficient. They will be designed and manufactured with atomic precision and less production waste. Out to 2020, defence applications, in convergence with other disciplines, are likely to be predominantly in sensors, electro-optics and materials, including biologically active agents and surface- engineered materials. Additionally, integrated nano-devices will lead to the emergence of small, swarmed and autonomous systems. The application of nanotechnologies, whether through materials or devices, will become pervasive and diverse, particularly in manufacturing (strong lightweight materials for transportation applications), synthetic reproduction, novel power (battery) sources and health care (targeted drug delivery and augmented medical treatments).

Much of it is sensible, but the term ‘synthetic reproduction’ pops up a few times, perhaps a hangover from the old nanobot days when planners envisaged hordes of nanobots devouring enemy tanks?

Where did they all go?

My colleague Dexter Johnson (aka the Nanoclast) highlights a forthcoming report about the decline in the number of Australian nanotech companies, but it’s hardly surprising. Before anyone heralds the death of anything consider this:

  • The global economy has resulted in a reduction of the number of companies in just about every sector of the economy. High streets where a third of the shops have closed are now common outside London, and everyone from estate agents to Starbucks have been rationalising, downsizing or going bust.
  • As I mentioned back in 2001, most nanomaterials companies will go bust, some sooner, some later, but there is almost no way that anyone apart from large diversified chemical and materials companies can create a sustainable business in that sector. Of course if you told your VCs that nanotubes were the new gold you probably got closed down five years ago.
  • Nanotech has been subject to a large amount of M&A activity, Singular ID being snapped up by Bilicare for example, thereby disappearing from the Singapore register of nanotech companies and joining the Indian pharmaceutical industry.
  • Most nanotech companies were start ups, and most start ups don’t survive too long, whatever the sector.
  • I can think of plenty of companies making use of nanotechnologies that no one would consider being nanotech companies, so how a nanotech company is defined is also part of the problem.

Of course I’m pre judging the report, and there may be more granularity and methodology than in this brief report. However what isn’t in doubt is the stupid and irresponsible nanotech market numbers that Lux Research keep repeating and which keeps finding its way into business plans and foresight documents. Any business plan that starts waffling on about the ‘nanotech market’ gets binned straight away. In our investment business we interested in tangible and quantifiable numbers not abstract, artificial and absurd concepts.

Now if I was working in a government agency which was being judged on the number of nanotechnology companies created/attracted/sustained I’d be looking trying to figure out how far and how fast I could move the goalposts.

Tagged with:
 

foxbatToday’s Times has four writers explaining their ‘Eureka Moments’ with science, and proving that a lifetime in the arts is no barrier to getting to grips with science.

I’ve spent the past couple of months going the other way, and getting involved in fashion! I’ve long been fascinated by the creative arts, but my enthusiasm has been unmatched by my skill with a paintbrush or even a soldering iron, both of which have in the past raised gasps of astonishment. However, I recently found a way to reconcile nanotechnology with fashion by opening a boutique, Foxbat, in one of London’s hippest districts, Spitalfields.

The idea came about last year when the Victoria and Albert Museum organised an exhibition called ‘China Design Now‘ which illustrated how art, design and fashion was undergoing a renaissance in China.

China is huge. China is becoming topical. Yet China remains mystery to most people in the West. ‘Made in China’ has become a familiar tag, but the spectacular creative energy in modern China is barely known. During the last twenty years, the Chinese have rediscovered their pre-socialist past and begun to combine their own traditions with global influences to produce a cultural rebirth. At the heart of this lies a new culture of design.

Spending time in China last year I was struck by the new home grown brands of fashion & jewellery that were emerging to stand alongside the more well known European brands and the ubiquitous (in Asia) Burberry, and the idea was born to import the best of Chinese and Korean design to Europe. The quality is outstanding, and given the disparity between consumer buying power in London and Shanghai, some thing that would cost the equivalent of a thousand pounds in China can be retailed in London for two hundred! So it’s high fashion at high street prices, a credit crunch business model that appealed to me.

We finally opened Foxbat last week, on Brushfield St in Old Spitalfields Market after six months of negotiating leases, dealing with builders, plumbers, electricians, window cleaners. A week before we were due to open our interior designers flounced out in a huff after we criticised their tiny fitting room mirrors, leaving us to source everything ourselves at short notice.

So what about the nanotechnology? We have one of the largest collections of NeoGlory crystal jewellery outside China. NeoGlory also make all the crystals for a well known Austrian brand, but have now moved into producing their own designs, which are equally stunning but at a fraction of the usual prices. As some people may know, the days of mining crystal from the Austrian Alps ended a long time ago, and most crystal used in jewellery is lead crystal, often coated with a few nanometers of metal film to add colour and enhance sparkle.

So moving from nanotechnology to a boutique full of shiny sparkly girly stuff isn’t such a great leap after all!

Tagged with:
 

I was puzzled by a recent HSBC report claiming that technology would transform the UK landscape with places like Dundee becoming a computer gaming hub and Newcastle, where much of the post industrial activity consists of handing out or receiving government benefits would be transformed by nanotechnology. The report seems to reveal a previously unknown Geordie fervour for science as they claim that “Newcastle will become a science city, with the sector ranked top among Geordies for investment or to start a business in.”

Other conclusions are that “Liverpool, for example, is set to become a centre of excellence in stem cell research, while Manchester is tipped as a leader in robotics.” and “Glasgow is predicted to become a centre for renewable energies.”

While I’m always happy to see that Leeds is predicted to be a super city rivalling the City of London with its financial skills, I suspend my disbelief mainly in the hope that it may one day have a super football club as well.

I’m never quite sure how these predictions are arrived at, but it seems to be along the lines of assuming that if Newcastle has twice as much nanotech going on as a few years ago then nanoscience will underpin the regions economy by 2030, although I have to conclude that many of the science based conclusions are complete twaddle. Here’s what it says about nanotech:

Nanotech :
Hot spots
Bristol – Cambridge – Durham –London – Newcastle – Oxford
Nanotechnology applies to a very broad field of science that focuses on the design and control of things on a minuscule scale. It has huge potential and is in current use in industries such as beauty, medicine and textiles. Richard Feynman, considered the father of nanotech, postulated in 1959 that, because it involves work at a minute level, nanotechnology would eventually enable us to build any substance from scratch.

Not too bad for a beginner, but I was truly shocked by their complete and utter rubbish written on Stem Cells:

Stem cell research :
Hot spots
Cambridge – Edinburgh –Liverpool – London – Manchester

The ageing population is driving the stem cell industry. Stem cells regenerate the skin and keep it looking youthful but diminish as we age.

Stem cell technology, traditionally used for burn patients, is seen as the holy grail of anti-ageing. One of the reasons the UK has become an international hotbed for the stem cell sector is the lack of industry legislation. Universities and
researchers are effectively operating in a legal vacuum.

So there we have it – technology hot spots predicted by a bunch of people who couldn’t even be bothered finding out what the technology actually is.

Tagged with:
 

It’s interesting that IBM seems to be the partner of choice for a number of nanotechnology in emerging economies such as Bulgaria and Egypt, (where there are large number of vacancies, including the post of “Centre Director.”)

IBM, as we all know, was responsible for the STM/AFM and holds a wide variety of nanotechnology related patents, including some fairly fundamental ones on carbon nanotubes. Partnering with these new centers allows IBM to double dip by providing services (now the core business) and encourage the exploitation of its patents – something that looks like a pretty smart strategy to me.

Tagged with:
 

I mentioned recently our work at Envision on the need to be able to rapidly distinguish between various strains of pathogens and how nanotechnology plays a part, but printable electronics plays a greater role than simply producing the detectors.

The beauty of being able to print devices is that costs become almost insignificant, so the critical semiconductor industry metric of yield, i.e. how many of the devices coming off the line are actually working, becomes insignificant. A wafer of microprocessors containing 800 chips retailing for $50 each is worth $40,000, and given the volume of processor manufactured, the effect of a a 2.5% improvement in yield of $1000/wafer soon stacks up. In contrast, printable electronics can produce devices for fractions of a cent (although nothing as complex as a microprocessor) and if these are retailing for a dollar the greater than 90% gross margins means that its not worth tweaking the system to get an improvement of a few percent in yield.

Talking to semiconductor industry people about plastic electronics often reaches an impasse with repeated demands to know what the expected yield of the process would be, and industry players often just not understanding the concept of yield not being significant when it is a measure that can make or lose millions of dollars a day for silicon based semiconductors.

But when we are talking about detecting swine flu (or Influenza (A) H1N1 as it has been re branded) one of the key issues is getting enough tests into the hands of the people who need them, and quickly. Changing a semiconductor process is costly and time consuming, because of the need to maintain high yields, whereas with the printed electronics solution, or at least the one we have, the device remains exactly the same whatever you are trying to detect, and it is only the antigen that needs to be changed whether we are looking for flu strains, bacteria or anything else.

Apart from the cost, which is always high on the agenda in any business, it is the flexibility of the approach which fascinates me. Whichever influenza strain we are looking for, only a small change in the antigen used needs to be made to produce a new detector. In fact, with the technology in its current state, a number of different antigens can be placed on the same chip, allowing positive identification of any one of a number of strains. So creating a new test, or opening up a new market only requires a minor tweak, rather than re engineering an entire process and losing sleep over small changes in yield.

Page 1 of 6123456